Agnieszka Wachsmann

Dr. Agnieszka Wachsmann


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Environmental Research
Verified
Journal Article
Closed access
MMMikołaj Maga
Mikołaj Maga
MJMaciej K. Janik
Maciej K. Janik
AWAgnieszka Wachsmann
Agnieszka Wachsmann
OCOlga Chrząstek-Janik
Olga Chrząstek-Janik
MHMateusz Krystian Hołda
Mateusz Krystian Hołda
RNRafał Niżankowski
Rafał Niżankowski

1 May 2019 in Environmental Research
Verified
Journal Article
Closed access
IGIwona Gregorczyk-Maga
Iwona Gregorczyk-Maga
MMMikołaj Maga
Mikołaj Maga
AWAgnieszka Wachsmann
Agnieszka Wachsmann
MJMaciej K. Janik
Maciej K. Janik
OCOlga Chrzastek-Janik
Olga Chrzastek-Janik
MKMateusz Koziej
Mateusz Koziej

31 May 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
MMMikołaj Maga
Mikołaj Maga
AWAgnieszka Wachsmann
Agnieszka Wachsmann
KBKrzysztof Batko
Krzysztof Batko
AWAleksandra Włodarczyk
Aleksandra Włodarczyk
PKPaulina Kłapacz
Paulina Kłapacz
AŚAgnieszka Śliwka
Agnieszka Śliwka
Despite growing evidence of the significant influence of blood-flow-restricted (BFR) training on different body functions, its impact on the vascular system, especially the arteries, is controversial. Therefore, the objective of our study was to analyze how BFR exercise, compared to other types of exercise without the restriction of blood flow, influences arterial functions and angiogenesis in adults. Studies comparing the effect of BFR versus non-BFR training on arterial parameters were divided into three categories: endothelial function, angiogenesis, and other vasculature functions. The search was based on Cochrane Library, PubMed®, and Embase, and 38 studies were included. The meta-analysis revealed a more significant improvement in flow-mediated dilatation (FMD) (p = 0.002) and the production of the primary angiogenesis biomarker vascular endothelial growth factor (VEGF) (p = 0.009) after BFR compared to non-BFR training (p = 0.002). The analysis of the pulse wave velocity, ankle-brachial index, systolic blood pressure, and heart rate did not show significant differences in changes between BFR and non-BFR training. The other parameters examined did not have sufficient data to be included in the meta-analysis. The results obtained present trends that suggest significant impacts of BFR training on endothelial functions and angiogenesis. There is still a lack of multicenter randomized clinical trials including many participants, and such studies are necessary to confirm the advantage of BFR over non-BFR activity.

24 November 2017 in Clinical Research in Cardiology
Verified
Journal Article
Open access
PDF file
WSWojciech Szczeklik
Wojciech Szczeklik
MKMarek Krzanowski
Marek Krzanowski
PMPaweł Maga
Paweł Maga
ŁPŁukasz Partyka
Łukasz Partyka
JKJolanta Kościelniak
Jolanta Kościelniak
PDP. J. Devereaux
P. J. Devereaux
Patients with critical limb ischemia (CLI) are at increased risk of cardiovascular complications and mortality. To determine (1) incidence of myocardial injury following endovascular revascularization, and (2) relationship between myocardial injury with 1-year mortality and major adverse cardiovascular events (MACE; i.e., composite of myocardial infarction, stroke, and death).

14 April 2016 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
PMPaweł Maga
Paweł Maga
MSM Sanak
M Sanak
BRB Rewerska
B Rewerska
MMMikołaj Maga
Mikołaj Maga
JJJ Jawien
J Jawien
NCN Celejewska-Wójcik
N Celejewska-Wójcik

Verified
Journal Article
Open access
PDF file
AWAgnieszka Wachsmann
Agnieszka Wachsmann
MMMikołaj Maga
Mikołaj Maga
Romuald PolczykRomuald Polczyk
Romuald Polczyk
AWAleksandra Włodarczyk
Aleksandra Włodarczyk
PPPatrycja Pasieka
Patrycja Pasieka
PMPaweł Maga
Paweł Maga
The association between chronic inflammation and depression, anxiety, anhedonia, and quality of life (QoL) has been recently emphasized. However, the pathophysiology of this relationship remains unsolved. This study aims to assess the dependence between vascular inflammation represented by eicosanoid concentration and quality of life in patients with peripheral arterial disease (PAD). A total of 175 patients undergoing endovascular treatment due to lower limbs ischemia were covered with eight years of observation after the endovascular procedure, including ankle-brachial index (ABI), color Doppler ultrasound examination, urinary leukotriene E4 (LTE4), thromboxane B2 (TXB2) and 5-Hydroxyeicosatetraenoic acid (5-HETE) measurement and quality-of-life assessment with VascuQol-6. The baseline concentrations of LTE4 and TXB2 reversely correlated with preoperative VascuQol-6 and were predictive of the postoperative values of VascuQol-6 at each follow-up. At every follow-up timepoint, the results of VascuQol-6 reflected the LTE4 and TXB2 concentrations. Higher concentrations of LTE4 and TXB2 were correlated with lower life quality during the next follow-up meeting. Changes in VascuQol-6 at eight years vs. preoperative values were reversely related to the preoperative concentrations of LTE4 and TXB2. This is the first study to confirm that changes in life quality in PAD patients undergoing endovascular treatment are highly dependent on eicosanoid-based vascular inflammation.